BioCentury | Sep 19, 2020
Translation in Brief
Gene therapies from Passage Bio, Locanabio; Lava’s antitumor bispecific, health disparities in Alzheimer’s and more
...Passage Bio Inc. reported that administration of PBFT02, an AAV1-GRN vector, led to elevated levels of PGRN...
...dementia caused by GRN mutations. Intra-cisterna magna injection of PBFT02 in rhesus macaques led to PGRN...
...investigate Alzheimer’s in underrepresented populations (see “NIH Taking Action”).TARGETSDMPK – Dystrophia myotonica-protein kinaseGRN – GranulinPGRN (PCDGF...
...dementia caused by GRN mutations. Intra-cisterna magna injection of PBFT02 in rhesus macaques led to PGRN...
...investigate Alzheimer’s in underrepresented populations (see “NIH Taking Action”).TARGETSDMPK – Dystrophia myotonica-protein kinaseGRN – GranulinPGRN (PCDGF...